Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Jan 25, 2021 45.40 -5.22   
 24Storage 24STOR Jan 25, 2021 41.10 +0.49   
 2cureX 2CUREX Jan 25, 2021 20.70 -4.17   
 A3 Allmänna IT- och Telekomaktiebolaget ATRE Jan 25, 2021 18.80 0.00   
 AAC Clyde Space AAC Jan 25, 2021 3.94 -2.36   
 AAK AAK Jan 25, 2021 159.30 +0.31   
 ABB ABB Jan 25, 2021 248.60 -0.76   
 Abelco Investment Group ABIG Jan 25, 2021 0.11 +0.90   
 ABG Sundal Collier Holding ASCO Jan 25, 2021 5.74 0.00   
 Abliva ABLI Jan 25, 2021 0.82 -4.77   
 Absolent Group ABSO Jan 25, 2021 420.00 -0.94   
 Absolicon ABSL Jan 25, 2021 128.50 -2.65   
 AcadeMedia ACAD Jan 25, 2021 79.60 -0.38   
 Acarix ACARIX Jan 25, 2021 1.41 +9.77   
 Acconeer ACCON Jan 25, 2021 28.90 -7.52   
 Acosense ACOS Jan 25, 2021 1.35 -3.57   
 AcouSort ACOU Jan 25, 2021 23.50 -3.69   
 Acrinova ACRI Jan 25, 2021 19.60 +0.51   
 ACROUD ACROUD Jan 25, 2021 2.81 +0.36   
 Actic Group ATIC Jan 25, 2021 17.10 +0.59   
 Active Biotech ACTI Jan 25, 2021 1.68 -3.68   
 AcuCort ACUC Jan 25, 2021 4.75 -5.00   
 Adapteo ADAPT Jan 25, 2021 92.00 -3.16   
 AdderaCare ADDERA Jan 25, 2021 4.26 -2.74   
 AddLife B ALIFB Jan 25, 2021 150.20 -0.27   
 Addnode Group B ANODB Jan 25, 2021 264.00 -1.12   
 Addtech B ADDTB Jan 25, 2021 114.00 -1.72   
 ADDvise Group A ADDVA Jan 25, 2021 1.75 0.00   
 ADDvise Group B ADDVB Jan 25, 2021 1.36 -6.21   
 Adevinta ADEO Jan 25, 2021 130.40 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK